In this podcast, Natalie D. Crawford, PhD, discusses the results of her team's recent study examining the potential benefits of pharmacy integration in increasing access and use of preexposure prophylaxis...
In this podcast, Jeffrey Kwong, DNP, MPH, ANP-BC, discusses the use of HIV pre-exposure prophylaxis (PrEP) in older adults, its safety and efficacy in this patient population, and what barriers exist for...
In this podcast, Jessica Rodrigues, with AVAC: Global Advocacy for HIV Prevention, speaks about ways communities can overcome barriers to the access of pre-exposure prophylaxis (PrEP), including ambitious...
In this podcast, Jessica Rodrigues, with AVAC: Global Advocacy for HIV Prevention, provides a description of a Dual Prevention Pill and why it can be used as a case study for future multipurpose...
In part 3 of this 3-part episode, Jeffrey Kwong, DNP, MPH, ANP-BC, discusses the benefits of HIV pre-exposure prophylaxis (PrEP) for women in preventing HIV, strategies for eliminating HIV globally,...
In part 2 of this 3-part episode, Jeffrey Kwong, DNP, MPH, ANP-BC, talks about how HIV pre-exposure prophylaxis (PrEP) has evolved over the years since becoming available for use in 2012 and the future of...
In part 1 of this 3-part series, Dr Jeffrey Kwong, DNP, MPH, ANP-BC, talks about the barriers patients may have to HIV Pre-exposure Prophylaxis (HIV PrEP)and what clinicians need to know when talking to...
In this podcast, Charles Flexner, MD, speaks about the current state of long-acting agents for the management of patients with HIV, HIV prevention and vaccines, and HIV pathogenesis and cure. Dr Flexner...
Joshua Khalili, MD, from UCLA, discusses his new paper published in JAMA Internal Medicine, which details the key role primary care practitioners play in prescribing pre-exposure prophylaxis to uninfected...
In this podcast, Michael Reid, MD, from University of California, San Francisco, discusses the newest HIV-TB prevention therapies, the latest research on a new tuberculosis vaccine, and more.
